6.
Chio A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E
. Prognostic factors in ALS: A critical review. Amyotroph Lateral Scler. 2009; 10(5-6):310-23.
PMC: 3515205.
DOI: 10.3109/17482960802566824.
View
7.
Asgari N, Lillevang S, Skejoe H, Falah M, Stenager E, Kyvik K
. A population-based study of neuromyelitis optica in Caucasians. Neurology. 2011; 76(18):1589-95.
PMC: 3269768.
DOI: 10.1212/WNL.0b013e3182190f74.
View
8.
Borisow N, Meyer T, Paul F
. Concomitant amyotrophic lateral sclerosis and paraclinical laboratory features of multiple sclerosis: coincidence or causal relationship?. BMJ Case Rep. 2013; 2013.
PMC: 3603947.
DOI: 10.1136/bcr-2012-007975.
View
9.
Uzawa A, Mori M, Kuwabara S
. Neuromyelitis optica: concept, immunology and treatment. J Clin Neurosci. 2013; 21(1):12-21.
DOI: 10.1016/j.jocn.2012.12.022.
View
10.
Garbuzova-Davis S, Sanberg P
. Blood-CNS Barrier Impairment in ALS patients versus an animal model. Front Cell Neurosci. 2014; 8:21.
PMC: 3910123.
DOI: 10.3389/fncel.2014.00021.
View
11.
Wingerchuk D, Banwell B, Bennett J, Cabre P, Carroll W, Chitnis T
. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015; 85(2):177-89.
PMC: 4515040.
DOI: 10.1212/WNL.0000000000001729.
View
12.
Walker-Caulfield M, Guo Y, Johnson R, McCarthy C, Fitz-Gibbon P, Lucchinetti C
. NFκB signaling drives pro-granulocytic astroglial responses to neuromyelitis optica patient IgG. J Neuroinflammation. 2015; 12:185.
PMC: 4590277.
DOI: 10.1186/s12974-015-0403-8.
View
13.
Flanagan E, Cabre P, Weinshenker B, St Sauver J, Jacobson D, Majed M
. Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum. Ann Neurol. 2016; 79(5):775-783.
PMC: 4988933.
DOI: 10.1002/ana.24617.
View
14.
Mehta P, Kaye W, Bryan L, Larson T, Copeland T, Wu J
. Prevalence of Amyotrophic Lateral Sclerosis - United States, 2012-2013. MMWR Surveill Summ. 2016; 65(8):1-12.
DOI: 10.15585/mmwr.ss6508a1.
View
15.
Migheli A, Piva R, Atzori C, Troost D, Schiffer D
. c-Jun, JNK/SAPK kinases and transcription factor NF-kappa B are selectively activated in astrocytes, but not motor neurons, in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol. 1997; 56(12):1314-22.
DOI: 10.1097/00005072-199712000-00006.
View